Patrick Auberger

26.6k total citations · 4 hit papers
193 papers, 10.5k citations indexed

About

Patrick Auberger is a scholar working on Molecular Biology, Immunology and Hematology. According to data from OpenAlex, Patrick Auberger has authored 193 papers receiving a total of 10.5k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Molecular Biology, 44 papers in Immunology and 40 papers in Hematology. Recurrent topics in Patrick Auberger's work include Cell death mechanisms and regulation (33 papers), Autophagy in Disease and Therapy (23 papers) and Chronic Myeloid Leukemia Treatments (22 papers). Patrick Auberger is often cited by papers focused on Cell death mechanisms and regulation (33 papers), Autophagy in Disease and Therapy (23 papers) and Chronic Myeloid Leukemia Treatments (22 papers). Patrick Auberger collaborates with scholars based in France, United States and Italy. Patrick Auberger's co-authors include Alexandre Puissant, Frédéric Luciano, Guillaume Robert, Arnaud Jacquel, Pascal Colosetti, Gilles Pagès, Frédéric Bost, Jean‐François Tanti, Bernard Rossi and Kathiane Laurent and has published in prestigious journals such as Science, Cell and Journal of Biological Chemistry.

In The Last Decade

Patrick Auberger

190 papers receiving 10.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level

2008 732 citations Issam Ben Sahra, Kathiane Laurent et al. profile →
Tyrosine Phosphorylation of IκB-α Activates NF-κB without Proteolytic Degradation of IκB-α

1996 597 citations Patrick Auberger et al. profile →
Defective Thymocyte Maturation in p44 MAP Kinase (Erk 1) Knockout Mice

1999 544 citations Patrick Auberger et al. profile →
Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1

2011 526 citations Claire Regazzetti, Guillaume Robert et al. Cancer Research profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Patrick Auberger	6.5k	2.1k	2.1k	1.9k	1.6k	193	10.5k
Marian H. Harris	6.8k 1.0×	1.6k 0.8×	4.2k 2.0×	1.9k 1.0×	1.6k 1.0×	78	11.1k
Emily H. Cheng	12.6k 1.9×	2.6k 1.3×	2.5k 1.2×	2.1k 1.1×	2.3k 1.4×	94	16.4k
Hui‐Kuan Lin	7.6k 1.2×	2.3k 1.1×	2.4k 1.2×	1.1k 0.6×	1.0k 0.6×	120	10.7k
Lorraine A. O’Reilly	5.5k 0.8×	1.6k 0.8×	990 0.5×	3.9k 2.1×	1.3k 0.8×	118	9.7k
Andreas Villunger	7.5k 1.2×	3.1k 1.5×	1.4k 0.7×	2.8k 1.5×	1.0k 0.6×	183	10.7k
David C. Seldin	9.8k 1.5×	2.9k 1.4×	961 0.5×	1.4k 0.8×	1.3k 0.8×	202	12.5k
Mark J. Arends	5.4k 0.8×	2.5k 1.2×	1.9k 0.9×	1.0k 0.6×	1.4k 0.8×	193	9.8k
Rebecca Taub	6.4k 1.0×	2.2k 1.1×	1.3k 0.6×	2.1k 1.1×	4.2k 2.5×	165	15.6k
Vincent W. Yang	9.6k 1.5×	1.4k 0.7×	1.6k 0.8×	785 0.4×	520 0.3×	192	12.9k
Atsushi Hirao	7.2k 1.1×	3.2k 1.5×	1.9k 0.9×	2.4k 1.3×	964 0.6×	132	12.4k

Countries citing papers authored by Patrick Auberger

Since Specialization

Citations

This map shows the geographic impact of Patrick Auberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Auberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Auberger more than expected).

Fields of papers citing papers by Patrick Auberger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Auberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Auberger. The network helps show where Patrick Auberger may publish in the future.

Co-authorship network of co-authors of Patrick Auberger

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Auberger. A scholar is included among the top collaborators of Patrick Auberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Auberger. Patrick Auberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Caron, Gersende, Tony Marchand, Laurent Delpy, et al.. (2025). PIM2 inhibition promotes MCL1 dependency in plasma cells involving integrated stress response-driven NOXA expression. Nature Communications. 16(1). 256–256. 1 indexed citations

Picou, Frédéric, Vilma Barroca, Nathalie Déchamps, et al.. (2023). The Antioxidant TEMPOL Protects Human Hematopoietic Stem Cells From Culture-Mediated Loss of Functions. Stem Cells Translational Medicine. 12(10). 676–688. 4 indexed citations

Chaintreuil, Paul, et al.. (2023). The generation, activation, and polarization of monocyte-derived macrophages in human malignancies. Frontiers in Immunology. 14. 1178337–1178337. 44 indexed citations

Solier, Stéphanie, Michele Mondini, Lydia Meziani, et al.. (2023). Caspase Inhibition Modulates Monocyte-Derived Macrophage Polarization in Damaged Tissues. International Journal of Molecular Sciences. 24(4). 4151–4151. 2 indexed citations

Mallavialle, Aude, Mélanie Tichet, Patrick Auberger, et al.. (2018). Targeting the Proteasome-Associated Deubiquitinating Enzyme USP14 Impairs Melanoma Cell Survival and Overcomes Resistance to MAPK-Targeting Therapies. Molecular Cancer Therapeutics. 17(7). 1416–1429. 44 indexed citations

Auberger, Patrick, et al.. (2018). ZNF224 is a transcriptional repressor of AXL in chronic myeloid leukemia cells. Biochimie. 154. 127–131. 12 indexed citations

Koering, Catherine, Delphine Maucort‐Boulch, Guillaume Robert, et al.. (2016). An miRNA–DNMT1 Axis Is Involved in Azacitidine Resistance and Predicts Survival in Higher-Risk Myelodysplastic Syndrome and Low Blast Count Acute Myeloid Leukemia. Clinical Cancer Research. 23(12). 3025–3034. 29 indexed citations

Bailleux, Caroline, Guillaume Robert, A. Thyss, et al.. (2014). Successful re-treatment of a relapsed V600E mutated HCL patient with low-dose vemurafenib. Oncoscience. 2(1). 44–49. 11 indexed citations

Robert, Guillaume, Alexandre Puissant, Maeva Dufies, et al.. (2012). The caspase 6 derived N-terminal fragment of DJ-1 promotes apoptosis via increased ROS production. Cell Death and Differentiation. 19(11). 1769–1778. 20 indexed citations

10.

Puissant, Alexandre, Maeva Dufies, Nina Fenouille, et al.. (2012). Imatinib triggers mesenchymal-like conversion of CML cells associated with increased aggressiveness. Journal of Molecular Cell Biology. 4(4). 207–220. 32 indexed citations

11.

Regazzetti, Claire, Guillaume Robert, Kathiane Laurent, et al.. (2011). Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1. Cancer Research. 71(13). 4366–4372. 526 indexed citations breakdown →

12.

Jacquel, Arnaud, Nathalie Droin, Patrick Auberger, et al.. (2011). Leukemic cell xenograft in zebrafish embryo for investigating drug efficacy. Haematologica. 96(4). 612–616. 100 indexed citations

13.

Fenouille, Nina, Alexandre Puissant, Maeva Dufies, et al.. (2010). Persistent Activation of the Fyn/ERK Kinase Signaling Axis Mediates Imatinib Resistance in Chronic Myelogenous Leukemia Cells through Upregulation of Intracellular SPARC. Cancer Research. 70(23). 9659–9670. 52 indexed citations

14.

Puissant, Alexandre, Guillaume Robert, Nina Fenouille, et al.. (2010). Resveratrol Promotes Autophagic Cell Death in Chronic Myelogenous Leukemia Cells via JNK-Mediated p62/SQSTM1 Expression and AMPK Activation. Cancer Research. 70(3). 1042–1052. 323 indexed citations

15.

Sahra, Issam Ben, Kathiane Laurent, Sandy Giuliano, et al.. (2010). Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells. Cancer Research. 70(6). 2465–2475. 434 indexed citations

16.

Grosso, Sébastien, Alexandre Puissant, Maeva Dufies, et al.. (2009). Gene expression profiling of imatinib and PD166326-resistant CML cell lines identifies Fyn as a gene associated with resistance to BCR-ABL inhibitors. Molecular Cancer Therapeutics. 8(7). 1924–1933. 67 indexed citations

17.

Lavallard, Vanessa, Ludivine A. Pradelli, Audrey Z. Paul, et al.. (2009). Modulation of Caspase-Independent Cell Death Leads to Resensitization of Imatinib Mesylate–Resistant Cells. Cancer Research. 69(7). 3013–3020. 23 indexed citations

18.

Defamie, Virginie, Raffaele Cursio, Kévin Le Brigand, et al.. (2008). Gene Expression Profiling of Human Liver Transplants Identifies an Early Transcriptional Signature Associated with Initial Poor Graft Function. American Journal of Transplantation. 8(6). 1221–1236. 32 indexed citations

19.

Py, Bénédicte F., Christian Slomianny, Patrick Auberger, Patrice X. Petit, & Serge Bénichou. (2004). Siva-1 and an Alternative Splice Form Lacking the Death Domain, Siva-2, Similarly Induce Apoptosis in T Lymphocytes via a Caspase-Dependent Mitochondrial Pathway. The Journal of Immunology. 172(7). 4008–4017. 70 indexed citations

20.

Aberdam, Édith, Patrick Auberger, Jean‐Paul Ortonne, & Robert Ballotti. (2000). Neprilysin, a Novel Target for Ultraviolet B Regulation of Melanogenesis Via Melanocortins. Journal of Investigative Dermatology. 115(3). 381–387. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact